Fucoidan Seaweed Supplement for Minimizing Fatigue and Inflammation for Cancer Survivors

Inclusion Criteria

• Survivors of cancer
• Age 18 or older
• Speak and understand English, the reason is that the patient reported outcomes being used have not been translated and validated in other languages as well as the lack of funding for translators
• Have completed surgery, radiation, and/or systemic intravenous anticancer therapy (e.g., chemotherapy, targeted therapy, immunotherapy) ≤ 10 years prior to enrollment
• Those on adjuvant hormonal therapy are eligible
• Women of child-bearing potential must agree to use adequate contraception, i.e., abstinence, intrauterine device (IUD), hormonal contraceptive (birth control pills) or barrier method (condoms) prior to study entry and for the duration of study participation. Men must agree to use adequate contraception i.e., barrier method (condoms) prior to study entry and for the duration of the study
• Have a baseline level of fatigue, as determined by reporting a score of 4 or higher for the question, "In the last week, how bad was your worst fatigue on a scale from 0-10?”
• Be willing to commit to the fucoidan supplement dosing and delivery method, to complete evaluation instruments, and to attend all study visits
• Completed informed consent

Exclusion Criteria

• Current use of any kind of anti-coagulation medication
• Current use of supplements that contain fucoidan
• Any allergy to fucoidan
• Be diagnosed with a major psychiatric illness requiring hospitalization within the last year
• Be diagnosed with dementia
• Must not have decisional impairment (cognitive impairment, mental impairment due to medication) as identified by electronical medical record
• Be pregnant or nursing